ID LAMB4_HUMAN Reviewed; 1761 AA. AC A4D0S4; A5PKU6; B2RTT3; B5MEB9; Q86TP7; Q86XN2; Q8NBX5; DT 04-DEC-2007, integrated into UniProtKB/Swiss-Prot. DT 03-APR-2007, sequence version 1. DT 27-MAR-2024, entry version 130. DE RecName: Full=Laminin subunit beta-4; DE AltName: Full=Laminin beta-1-related protein; DE Flags: Precursor; GN Name=LAMB4; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Placenta; RA Olson P.F., Koch M., Champliaud M.F., Rowland K., Jin W., Burgeson R.E.; RT "Cloning and characterization of the human laminin beta-4 chain."; RL Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=12853948; DOI=10.1038/nature01782; RA Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., RA Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., RA Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., RA Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H., RA Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A., RA Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P., RA Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M., RA Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S., RA Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., RA Strowmatt C., Latreille P., Miller N., Johnson D., Murray J., RA Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., RA Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., RA Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E., RA Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E., RA Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A., RA Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A., RA Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R., RA McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H., RA Wilson R.K.; RT "The DNA sequence of human chromosome 7."; RL Nature 424:157-164(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND NUCLEOTIDE RP SEQUENCE [LARGE SCALE MRNA] OF 975-1761 (ISOFORM 3). RC TISSUE=Testis; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1528-1761 (ISOFORM 1). RC TISSUE=Placenta; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [6] RP VARIANT CYS-1028. RX PubMed=25787250; DOI=10.1073/pnas.1503696112; RA Cromer M.K., Choi M., Nelson-Williams C., Fonseca A.L., Kunstman J.W., RA Korah R.M., Overton J.D., Mane S., Kenney B., Malchoff C.D., Stalberg P., RA Akerstroem G., Westin G., Hellman P., Carling T., Bjoerklund P., RA Lifton R.P.; RT "Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in RT insulin-producing adenomas."; RL Proc. Natl. Acad. Sci. U.S.A. 112:4062-4067(2015). CC -!- FUNCTION: Binding to cells via a high affinity receptor, laminin is CC thought to mediate the attachment, migration and organization of cells CC into tissues during embryonic development by interacting with other CC extracellular matrix components. CC -!- SUBUNIT: Laminin is a complex glycoprotein, consisting of three CC different polypeptide chains (alpha, beta, gamma), which are bound to CC each other by disulfide bonds into a cross-shaped molecule comprising CC one long and three short arms with globules at each end. CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular CC matrix, basement membrane. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=A4D0S4-1; Sequence=Displayed; CC Name=2; CC IsoId=A4D0S4-2; Sequence=VSP_029913, VSP_029914; CC Name=3; CC IsoId=A4D0S4-3; Sequence=VSP_029915, VSP_029916; CC -!- DOMAIN: The alpha-helical domains I and II are thought to interact with CC other laminin chains to form a coiled coil structure. CC -!- DOMAIN: Domains VI and IV are globular. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF028816; AAC95123.1; -; mRNA. DR EMBL; AC005048; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH236947; EAL24387.1; -; Genomic_DNA. DR EMBL; BC045172; AAH45172.2; -; mRNA. DR EMBL; BC140804; AAI40805.1; -; mRNA. DR EMBL; BC142619; AAI42620.1; -; mRNA. DR EMBL; AK075165; -; NOT_ANNOTATED_CDS; mRNA. DR CCDS; CCDS34732.1; -. [A4D0S4-1] DR CCDS; CCDS83218.1; -. [A4D0S4-2] DR RefSeq; NP_001304975.1; NM_001318046.1. [A4D0S4-1] DR RefSeq; NP_001304977.1; NM_001318048.1. DR RefSeq; NP_031382.2; NM_007356.2. [A4D0S4-1] DR RefSeq; XP_011514280.1; XM_011515978.1. [A4D0S4-3] DR AlphaFoldDB; A4D0S4; -. DR SMR; A4D0S4; -. DR BioGRID; 116479; 3. DR IntAct; A4D0S4; 1. DR STRING; 9606.ENSP00000373433; -. DR ChEMBL; CHEMBL2364187; -. DR GlyCosmos; A4D0S4; 16 sites, No reported glycans. DR GlyGen; A4D0S4; 16 sites. DR iPTMnet; A4D0S4; -. DR PhosphoSitePlus; A4D0S4; -. DR BioMuta; LAMB4; -. DR jPOST; A4D0S4; -. DR MassIVE; A4D0S4; -. DR PaxDb; 9606-ENSP00000373433; -. DR PeptideAtlas; A4D0S4; -. DR ProteomicsDB; 592; -. [A4D0S4-1] DR ProteomicsDB; 593; -. [A4D0S4-2] DR ProteomicsDB; 594; -. [A4D0S4-3] DR Antibodypedia; 62084; 49 antibodies from 12 providers. DR DNASU; 22798; -. DR Ensembl; ENST00000205386.8; ENSP00000205386.4; ENSG00000091128.13. [A4D0S4-1] DR Ensembl; ENST00000388781.8; ENSP00000373433.3; ENSG00000091128.13. [A4D0S4-1] DR GeneID; 22798; -. DR KEGG; hsa:22798; -. DR MANE-Select; ENST00000388781.8; ENSP00000373433.3; NM_007356.3; NP_031382.2. DR UCSC; uc003vey.3; human. [A4D0S4-1] DR AGR; HGNC:6491; -. DR CTD; 22798; -. DR DisGeNET; 22798; -. DR GeneCards; LAMB4; -. DR HGNC; HGNC:6491; LAMB4. DR HPA; ENSG00000091128; Tissue enriched (skin). DR MIM; 616380; gene. DR neXtProt; NX_A4D0S4; -. DR OpenTargets; ENSG00000091128; -. DR PharmGKB; PA30279; -. DR VEuPathDB; HostDB:ENSG00000091128; -. DR eggNOG; KOG0994; Eukaryota. DR GeneTree; ENSGT00940000162514; -. DR HOGENOM; CLU_001560_1_0_1; -. DR InParanoid; A4D0S4; -. DR OMA; RRCSCHP; -. DR OrthoDB; 90222at2759; -. DR PhylomeDB; A4D0S4; -. DR TreeFam; TF312903; -. DR PathwayCommons; A4D0S4; -. DR SignaLink; A4D0S4; -. DR BioGRID-ORCS; 22798; 22 hits in 1144 CRISPR screens. DR ChiTaRS; LAMB4; human. DR GenomeRNAi; 22798; -. DR Pharos; A4D0S4; Tbio. DR PRO; PR:A4D0S4; -. DR Proteomes; UP000005640; Chromosome 7. DR RNAct; A4D0S4; Protein. DR Bgee; ENSG00000091128; Expressed in skin of abdomen and 113 other cell types or tissues. DR ExpressionAtlas; A4D0S4; baseline and differential. DR GO; GO:0005604; C:basement membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW. DR GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW. DR CDD; cd22301; cc_LAMB4_C; 1. DR CDD; cd00055; EGF_Lam; 12. DR Gene3D; 2.60.120.260; Galactose-binding domain-like; 1. DR Gene3D; 2.10.25.10; Laminin; 11. DR Gene3D; 2.170.300.10; Tie2 ligand-binding domain superfamily; 1. DR InterPro; IPR013015; Laminin_IV_B. DR InterPro; IPR008211; Laminin_N. DR InterPro; IPR002049; LE_dom. DR PANTHER; PTHR10574:SF435; LAMININ SUBUNIT GAMMA-1; 1. DR PANTHER; PTHR10574; NETRIN/LAMININ-RELATED; 1. DR Pfam; PF00053; Laminin_EGF; 12. DR Pfam; PF21199; LAMININ_IV_B; 1. DR Pfam; PF00055; Laminin_N; 1. DR PRINTS; PR00011; EGFLAMININ. DR SMART; SM00180; EGF_Lam; 13. DR SMART; SM00136; LamNT; 1. DR SUPFAM; SSF57196; EGF/Laminin; 13. DR PROSITE; PS00022; EGF_1; 10. DR PROSITE; PS01186; EGF_2; 2. DR PROSITE; PS01248; EGF_LAM_1; 11. DR PROSITE; PS50027; EGF_LAM_2; 13. DR PROSITE; PS51116; LAMININ_IVB; 1. DR PROSITE; PS51117; LAMININ_NTER; 1. DR Genevisible; A4D0S4; HS. PE 2: Evidence at transcript level; KW Alternative splicing; Basement membrane; Cell adhesion; Coiled coil; KW Disulfide bond; Extracellular matrix; Glycoprotein; KW Laminin EGF-like domain; Reference proteome; Repeat; Secreted; Signal. FT SIGNAL 1..19 FT /evidence="ECO:0000255" FT CHAIN 20..1761 FT /note="Laminin subunit beta-4" FT /id="PRO_0000312857" FT DOMAIN 24..264 FT /note="Laminin N-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00466" FT DOMAIN 265..331 FT /note="Laminin EGF-like 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 332..394 FT /note="Laminin EGF-like 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 395..454 FT /note="Laminin EGF-like 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 455..505 FT /note="Laminin EGF-like 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 506..552 FT /note="Laminin EGF-like 5; truncated" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 545..763 FT /note="Laminin IV type B" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00462" FT DOMAIN 769..816 FT /note="Laminin EGF-like 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 817..862 FT /note="Laminin EGF-like 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 863..910 FT /note="Laminin EGF-like 8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 911..969 FT /note="Laminin EGF-like 9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 970..1021 FT /note="Laminin EGF-like 10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 1022..1079 FT /note="Laminin EGF-like 11" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 1080..1127 FT /note="Laminin EGF-like 12" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DOMAIN 1128..1174 FT /note="Laminin EGF-like 13" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT REGION 1175..1375 FT /note="Domain II" FT REGION 1376..1408 FT /note="Domain alpha" FT REGION 1409..1761 FT /note="Domain I" FT COILED 1243..1301 FT /evidence="ECO:0000255" FT COILED 1416..1480 FT /evidence="ECO:0000255" FT COILED 1525..1759 FT /evidence="ECO:0000255" FT CARBOHYD 169 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 229 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 246 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1016 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1055 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1223 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1301 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1326 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1333 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1354 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1469 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1517 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1587 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1596 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1609 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1725 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 265..?274 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 267..295 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 297..306 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 309..329 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 332..341 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 334..359 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 362..371 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 374..392 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 395..408 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 397..423 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 425..434 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 437..452 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 455..468 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 457..475 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 477..486 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 489..503 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 506..518 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 508..525 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 527..536 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 769..781 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 771..788 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 790..799 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 802..814 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 817..829 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 819..836 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 838..847 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 850..860 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 863..872 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 865..879 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 882..891 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 894..908 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 913..938 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 940..949 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 952..967 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 970..984 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 972..991 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 994..1003 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1006..1019 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1022..1043 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1024..1050 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1052..1061 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1064..1077 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1080..1092 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1082..1099 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1101..1110 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1113..1125 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1128..1140 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1130..1147 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1149..1158 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1161..1172 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00460" FT DISULFID 1175 FT /note="Interchain" FT /evidence="ECO:0000305" FT DISULFID 1178 FT /note="Interchain" FT /evidence="ECO:0000305" FT DISULFID 1759 FT /note="Interchain" FT /evidence="ECO:0000305" FT VAR_SEQ 709..772 FT /note="LGLIPQINSLENFCSKQDLDEYQLHNCVEIASAMGPQVLPGACERLIISMSA FT KLHDGAVACKCH -> AAVQWHNLGSLQPPPPECKQFSCFSFPSSWDYRHPPPHLASFC FT IFSRDGVSPHWPGWSRTPDLR (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_029913" FT VAR_SEQ 773..1761 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_029914" FT VAR_SEQ 1716..1723 FT /note="DLERKIQD -> GCFQNSAR (in isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_029915" FT VAR_SEQ 1724..1761 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_029916" FT VARIANT 44 FT /note="M -> T (in dbSNP:rs35644375)" FT /id="VAR_037588" FT VARIANT 234 FT /note="H -> Y (in dbSNP:rs2074749)" FT /id="VAR_037589" FT VARIANT 591 FT /note="V -> F (in dbSNP:rs9690688)" FT /id="VAR_037590" FT VARIANT 866 FT /note="N -> S (in dbSNP:rs2240445)" FT /id="VAR_037591" FT VARIANT 1028 FT /note="G -> C (in dbSNP:rs1299564647)" FT /evidence="ECO:0000269|PubMed:25787250" FT /id="VAR_074174" FT VARIANT 1350 FT /note="T -> N (in dbSNP:rs10260756)" FT /id="VAR_037592" FT VARIANT 1510 FT /note="H -> Y (in dbSNP:rs1627354)" FT /id="VAR_037593" FT VARIANT 1612 FT /note="R -> S (in dbSNP:rs2528693)" FT /id="VAR_037594" FT CONFLICT 70 FT /note="F -> S (in Ref. 1; AAC95123)" FT /evidence="ECO:0000305" FT CONFLICT 93 FT /note="I -> T (in Ref. 1; AAC95123)" FT /evidence="ECO:0000305" FT CONFLICT 1542 FT /note="L -> S (in Ref. 1; AAC95123)" FT /evidence="ECO:0000305" SQ SEQUENCE 1761 AA; 193540 MW; 57A740F079CE1FB2 CRC64; MQFQLTLFLH LGWLSYSKAQ DDCNRGACHP TTGDLLVGRN TQLMASSTCG LSRAQKYCIL SYLEGEQKCF ICDSRFPYDP YDQPNSHTIE NVIVSFEPDR EKKWWQSENG LDHVSIRLDL EALFRFSHLI LTFKTFRPAA MLVERSTDYG HNWKVFKYFA KDCATSFPNI TSGQAQGVGD IVCDSKYSDI EPSTGGEVVL KVLDPSFEIE NPYSPYIQDL VTLTNLRINF TKLHTLGDAL LGRRQNDSLD KYYYALYEMI VRGSCFCNGH ASECRPMQKM RGDVFSPPGM VHGQCVCQHN TDGPNCERCK DFFQDAPWRP AADLQDNACR SCSCNSHSSR CHFDMTTYLA SGGLSGGVCE DCQHNTEGQH CDRCRPLFYR DPLKTISDPY ACIPCECDPD GTISGGICVS HSDPALGSVA GQCLCKENVE GAKCDQCKPN HYGLSATDPL GCQPCDCNPL GSLPFLTCDV DTGQCLCLSY VTGAHCEECT VGYWGLGNHL HGCSPCDCDI GGAYSNVCSP KNGQCECRPH VTGRSCSEPA PGYFFAPLNF YLYEAEEATT LQGLAPLGSE TFGQSPAVHV VLGEPVPGNP VTWTGPGFAR VLPGAGLRFA VNNIPFPVDF TIAIHYETQS AADWTVQIVV NPPGGSEHCI PKTLQSKPQS FALPAATRIM LLPTPICLEP DVQYSIDVYF SQPLQGESHA HSHVLVDSLG LIPQINSLEN FCSKQDLDEY QLHNCVEIAS AMGPQVLPGA CERLIISMSA KLHDGAVACK CHPQGSVGSS CSRLGGQCQC KPLVVGRCCD RCSTGSYDLG HHGCHPCHCH PQGSKDTVCD QVTGQCPCHG EVSGRRCDRC LAGYFGFPSC HPCPCNRFAE LCDPETGSCF NCGGFTTGRN CERCIDGYYG NPSSGQPCRP CLCPDDPSSN QYFAHSCYQN LWSSDVICNC LQGYTGTQCG ECSTGFYGNP RISGAPCQPC ACNNNIDVTD PESCSRVTGE CLRCLHNTQG ANCQLCKPGH YGSALNQTCR RCSCHASGVS PMECPPGGGA CLCDPVTGAC PCLPNVTGLA CDRCADGYWN LVPGRGCQSC DCDPRTSQSS HCDQLTGQCP CKLGYGGKRC SECQENYYGD PPGRCIPCDC NRAGTQKPIC DPDTGMCRCR EGVSGQRCDR CARGHSQEFP TCLQCHLCFD QWDHTISSLS KAVQGLMRLA ANMEDKRETL PVCEADFKDL RGNVSEIERI LKHPVFPSGK FLKVKDYHDS VRRQIMQLNE QLKAVYEFQD LKDTIERAKN EADLLLEDLQ EEIDLQSSVL NASIADSSEN IKKYYHISSS AEKKINETSS TINTSANTRN DLLTILDTLT SKGNLSLERL KQIKIPDIQI LNEKVCGDPG NVPCVPLPCG GALCTGRKGH RKCRGPGCHG SLTLSTNALQ KAQEAKSIIR NLDKQVRGLK NQIESISEQA EVSKNNALQL REKLGNIRNQ SDSEEENINL FIKKVKNFLL EENVPPEDIE KVANGVLDIH LPIPSQNLTD ELVKIQKHMQ LCEDYRTDEN RLNEEADGAQ KLLVKAKAAE KAANILLNLD KTLNQLQQAQ ITQGRANSTI TQLTANITKI KKNVLQAENQ TREMKSELEL AKQRSGLEDG LSLLQTKLQR HQDHAVNAKV QAESAQHQAG SLEKEFVELK KQYAILQRKT STTGLTKETL GKVKQLKDAA EKLAGDTEAK IRRITDLERK IQDLNLSRQA KADQLRILED QVVAIKNEIV EQEKKYARCY S //